title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Stocks That Hit 52-Week Lows On Wednesday,20220511T162815,https://www.benzinga.com/markets/options/22/05/27141482/52-weeks-high-and-low-article,GRPH,0.006905,Neutral,-0.00124
Stocks That Hit 52-Week Lows On Friday,20220408T163534,https://www.benzinga.com/news/22/04/26547302/stocks-that-hit-52-week-lows-on-friday,GRPH,0.011399,Neutral,-0.022774
Stocks That Hit 52-Week Lows On Friday,20220401T170001,https://www.benzinga.com/news/22/04/26425809/stocks-that-hit-52-week-lows-on-friday,GRPH,0.021113,Neutral,-0.006129
Stocks That Hit 52-Week Lows On Thursday,20220331T181044,https://www.benzinga.com/news/22/03/26401822/stocks-that-hit-52-week-lows-on-thursday,GRPH,0.02511,Neutral,0.013945
Stocks That Hit 52-Week Lows On Monday,20220328T154408,https://www.benzinga.com/news/22/03/26326033/stocks-that-hit-52-week-lows-on-monday,GRPH,0.016131,Neutral,0.00292
Stocks That Hit 52-Week Lows On Tuesday,20220524T161351,https://www.benzinga.com/markets/options/22/05/27375519/52-weeks-high-and-low-article,GRPH,0.010175,Bearish,-0.529897
"The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs",20220503T130106,https://www.benzinga.com/general/biotech/22/05/26958446/the-daily-biotech-pulse-fdas-adcomm-for-acadias-pimavanserin-review-issues-for-speros-tebipenem-a,GRPH,0.093507,Neutral,0.084375
